| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | BIOPHARMX CORP COM | 57,656 | 32,000 | 0.02% | ||
| 2 | Vascular Biogenics Ltd | 33,332 | 174,000 | 0.11% | ||
| 3 | VERASTEM INC COM | 336,000 | 447,000 | 0.27% | ||
| 4 | VistaGen Therapeutics Inc | 138,132 | 575,000 | 0.35% | ||
| 5 | OPHTHOTECH CORP COM | 24,000 | 1,107,000 | 0.68% | ||
| 6 | Foamix Pharmaceuticals Ltd. | 125,000 | 1,158,000 | 0.71% | ||
| 7 | AXOVANT SCIENCES LTD | 100,000 | 1,400,000 | 0.86% | ||
| 8 | CONCERT PHARMACEUTICALS INC COM | 167,866 | 1,697,000 | 1.04% | ||
| 9 | AERIE PHARMACEUTICALS INC | 50,000 | 1,887,000 | 1.16% | ||
| 10 | ABEONA THERAPEUTICS INC | 321,609 | 1,930,000 | 1.19% | ||
| 11 | TREVENA INC | 298,849 | 2,017,000 | 1.24% | ||
| 12 | ADVAXIS INC COM NEW | 200,000 | 2,138,000 | 1.31% | ||
| 13 | PROGENICS PHARMACEUTICALS IN | 350,000 | 2,216,000 | 1.36% | ||
| 14 | IMMUNE DESIGN CORP COM | 305,000 | 2,312,000 | 1.42% | ||
| 15 | NEURODERM LTD | 131,000 | 2,422,000 | 1.49% | ||
| 16 | FIBROGEN INC COM | 127,680 | 2,643,000 | 1.62% | ||
| 17 | Ascendis Pharma | 146,200 | 2,939,000 | 1.81% | ||
| 18 | ZOGENIX INC | 260,000 | 2,972,000 | 1.83% | ||
| 19 | EIGER BIOPHARMACEUTICALS INC | 264,000 | 3,535,000 | 2.17% | ||
| 20 | COLUCID PHARMACEUTICALS INC COM | 100,000 | 3,815,000 | 2.34% | ||
| 21 | IMMUNOMEDICS INC | 1,263,276 | 4,106,000 | 2.52% | ||
| 22 | CLOVIS ONCOLOGY INC | 120,000 | 4,326,000 | 2.66% | ||
| 23 | LANNET INC COM NEW | 167,000 | 4,437,000 | 2.73% | ||
| 24 | Aquinox Pharmaceuticals Inc | 340,000 | 4,542,000 | 2.79% | ||
| 25 | ADAMAS PHARMACEUTICALS INC | 278,740 | 4,574,000 | 2.81% | ||
| 26 | INSMED INC COM PAR .01 | 322,044 | 4,676,000 | 2.87% | ||
| 27 | SEATTLE GENETICS INC | 111,500 | 6,022,000 | 3.70% | ||
| 28 | ACCELERON PHARMA | 217,817 | 7,883,000 | 4.84% | ||
| 29 | AstraZeneca PLC | 250,000 | 8,215,000 | 5.05% | Call | |
| 30 | SHIRE PLC | 67,000 | 12,989,000 | 7.98% | ||
| 31 | GLAXOSMITHKLINE PLC | 345,000 | 14,880,000 | 9.14% | ||
| 32 | PFIZER INC | 654,051 | 22,153,000 | 13.61% | ||
| 33 | SPDR S&P BIOTECH ETF | 400,000 | 26,516,000 | 16.29% | Put |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001646343-16-000010, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
